Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-035104

Director bought 49,125 shares at an average $43.27 ($2,125,795)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lamond David Director 2020-06-04 Purchase +13,609 $42.13 $573,377 1,711,593 I
Lamond David Director 2020-06-04 Purchase +10,642 $43.32 $461,034 1,722,235 I
Lamond David Director 2020-06-04 Purchase +24,874 $43.88 $1,091,384 1,747,109 I
Open-market purchases · 49,125 sh · avg $43.27 · $2,125,795
Loading xslF345X03/doc4.xml…